Dr. George Maylin

The Schenectady Supreme Court issued a temporary restraining order Thursday that put a halt on the New York Gaming Commission's efforts to disqualify Forte (Violence) from his win in the 2022 GI Hopeful S. at Saratoga and suspend trainer Todd Pletcher. Acting on behalf of Pletcher and owners Mike Repole and Vinnie Viola, attorney Drew Mollica filed an Article 78 appeal. Article 78 appeals are lawsuits mainly used to challenge an action, or inaction, by agencies of New York State and local governments. The New York Gaming Commission has alleged...

Forte (Violence) has been disqualified from the Sept. 5, 2022 GI Hopeful S. due to the presence of meloxicam in his system, according to the horse's owner, Mike Repole; his trainer, Todd Pletcher; and their lawyer, Karen Murphy, who held a phone conference Thursday afternoon to address the suspension. Meloxicam is a non-steroidal anti-inflammatory drug, widely prescribed to treat osteoarthritis and rheumatoid arthritis, and is sold under the brand name Mobic. It is not one of the non-steroidal anti-inflammatories that is approved in the United States for the treatment of...

The debate over whether or not Medina Spirit's 2021 GI Kentucky Derby disqualification for betamethasone was the result of an injection or the application of an ointment was a focal point in the fourth day of testimony at Bob Baffert's appeal before a Kentucky Horse Racing Commission (KHRC) hearing officer in Frankfort, Kentucky, on Thursday. That argument has percolated for the better part of 16 months in various hearing and courtroom settings. It is now being brought up again in front of the KHRC hearing officer to adjudicate the Hall-of-Fame...

Dr. George Maylin, the director of the New York Equine Drug Testing Programs, has confirmed the presence of IOX-2, a small molecule synthetic doping agent and a threat to both human and equine sport, in a pair of Standardbred horses racing at Yonkers Raceway. IOX-2 is a blood and gene doping agent that Dr. Maylin warned attendees about at the annual ARCI conference in Arcadia, California. The New York horseracing lab is believed to be the first--either in horse racing or the worldwide WADA network of testing labs--to screen for...